UBS maintains Qiagen at Neutral, PT $50.00
An UBS analyst maintained Qiagen (NYSE: QGEN) at Neutral and a price target of $50.00 from a prior price target of $52.00. Prior to this rating, Qiagen had 6 buy ratings, 8 hold ratings,...
Strong Buy
or
Qiagen News & Analysis
-
-
HSBC maintains Qiagen at Buy, PT $64.00
A HSBC analyst maintained Qiagen (NYSE: QGEN) at Buy and a price target of $64.00 from a prior price target of $62.00. Prior to this rating, Qiagen had 6 buy ratings, 8 hold ratings, and...
-
SOPHiA GENETICS and Qiagen Partner to Combine Strengths in Next-generation Sequencing
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced a new partnership with QIAGEN N.V. (QGEN) that will pair QIAseq reagent technology...
-
Qiagen Tops Q1 EPS by 6c
Qiagen (QGEN) reported Q1 EPS of $0.53, $0.06 better than the analyst estimate of $0.47. Revenue for the quarter came in at $498 million versus the consensus estimate of $489.92...
-
6 big deal reports: SAP mulls sale of Qualtrics stake
By Davit Kirakosyan Investing.com -- In one of the biggest M&A announcements this past week, |SAP said it may unload its stake in |Qualtrics. Here’s the full list of the most...
-
Lyft, Take-Two, TripAdvisor fall premarket; Coty, Dupont rise
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Tuesday, November 8th. Please refresh for updates. Lyft (NASDAQ:LYFT) stock fell 16% after the ride-hailing firm...
-
Qiagen Tops Q3 EPS by 8c
Qiagen (QGEN) reported Q3 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter came in at $500 million versus the consensus estimate of $481.71...
-
3 Rumors Buzzing Around Wall Street Today
By Investing.com Staff Stocks fell again Monday with the Nasdaq closing at a two-year low. Despite the sell-off, several rumors drove trading action in some select stocks today. Below we...
-
Bio-Rad Labs and Qiagen in Combination Talks - WSJ
By Sam Boughedda Shares of diagnostics firm Bio-Rad Laboratories Inc (NYSE:BIO) spiked higher before falling on Monday after a report from The Wall Street Journal said the company is in...
-
Qiagen Tops Q2 EPS by 5c; Raises Outlook
Qiagen (NYSE:QGEN) reported Q2 EPS of $0.51, $0.05 better than the analyst estimate of $0.46. Revenue for the quarter came in at $516 million versus the consensus estimate of $505.01...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
